🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

4+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 4 of 4 recruiting trials for “Blastic plasmacytoid dendritic cell neoplasm”

Phase 1, PHASE2RecruitingNCT06006403 ↗

Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm

👨‍⚕️ Jia Wei, M.D, Shanxi Bethune Hospital📍 1 site📅 Started Aug 2023View details ↗
RecruitingNCT05430971 ↗

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

👨‍⚕️ Astghik Voskanyan, MD, Immune Oncology Research Institute, Yerevan, Armenia📍 20 sites📅 Started Jul 2022View details ↗
Phase 2RecruitingNCT04216524 ↗

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

👨‍⚕️ Naveen Pemmaraju, M.D. Anderson Cancer Center📍 1 site📅 Started May 2020View details ↗
Phase 1RecruitingNCT03113643 ↗

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

👨‍⚕️ Andrew Lane, MD, PhD, Dana-Farber Cancer Institute📍 3 sites📅 Started Jun 2017View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →